Form 8-K - Current report:
SEC Accession No. 0001193125-24-073819
Filing Date
2024-03-21
Accepted
2024-03-21 16:01:03
Documents
13
Period of Report
2024-03-15
Items
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement

Document Format Files

Seq Description Document Type Size
1 8-K d808084d8k.htm   iXBRL 8-K 24159
  Complete submission text file 0001193125-24-073819.txt   146938

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bttx-20240315.xsd EX-101.SCH 2893
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE bttx-20240315_lab.xml EX-101.LAB 17979
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bttx-20240315_pre.xml EX-101.PRE 11287
17 EXTRACTED XBRL INSTANCE DOCUMENT d808084d8k_htm.xml XML 3651
Mailing Address 548 MARKET ST. #49404 SAN FRANCISCO CA 94101
Business Address 548 MARKET ST. #49404 SAN FRANCISCO CA 94101 415-887-2311
Better Therapeutics, Inc. (Filer) CIK: 0001832415 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39864 | Film No.: 24771213
SIC: 8000 Services-Health Services
(CF Office: 08 Industrial Applications and Services)